Viewing Study NCT01571661


Ignite Creation Date: 2025-12-24 @ 12:18 PM
Ignite Modification Date: 2026-01-24 @ 9:45 PM
Study NCT ID: NCT01571661
Status: COMPLETED
Last Update Posted: 2012-04-05
First Post: 2012-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None KGT-1142 View
None safety View
None pharmacokinetics View
None single-dose escalation View
None tolerability View